A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results
- 1 July 2002
- journal article
- clinical trial
- Published by Elsevier BV in Osteoarthritis and Cartilage
- Vol. 10 (7), 518-527
- https://doi.org/10.1053/joca.2001.0513
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical resultsOsteoarthritis and Cartilage, 2002
- The Concept of Clinically Meaningful Difference in Health-Related Quality of Life ResearchPharmacoEconomics, 2000
- A Comprehensive League Table of Cost-Utility Ratios and a Sub-table of "Panel-worthy" StudiesMedical Decision Making, 2000
- Comparison of Finnish and U.S.-based Visual Analog Scale Valuations of the EQ-5D MeasureMedical Decision Making, 2000
- Guidelines for authors and peer reviewers of economic submissions to the BMJBMJ, 1996
- Guidelines for the medical management of osteoarthritisArthritis & Rheumatism, 1995
- Multi-Attribute Preference FunctionsPharmacoEconomics, 1995
- Costs of elective total hip arthroplasty during the first year: Cemented versus noncementedThe Journal of Arthroplasty, 1994
- Cost-effectiveness league tables: More harm than good?Social Science & Medicine (1982), 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992